Showing results (2611-2620 of 10,006) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|July 18, 2022
The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantationElisa De Togni, Fei Wan, Michael Slade, et al.
Leukemia & Lymphoma|July 29, 2022
Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapyChristopher R Weil, Matthew J Parsons, Ryan J Hutten, et al.
Leukemia & Lymphoma|October 11, 2017
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphomaEmanuele Cencini, Benedetta Puccini, Luigi Rigacci, et al.
Leukemia & Lymphoma|September 25, 2019
Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO studyRong Deng, Leonid Gibiansky, Tong Lu, et al.
Leukemia & Lymphoma|March 30, 2017
Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?William M Rafelson, John L Reagan, Loren D Fast, et al.
Leukemia & Lymphoma|January 14, 2017
Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal modelTing Wang, Peipei Xu, Fan Wang, et al.
Leukemia & Lymphoma|January 18, 2017
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study GroupNorbert Grzasko, Roman Hajek, Marek Hus, et al.
Leukemia & Lymphoma|January 18, 2017
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre studyVijay Dhanapal, Menaka Gunasekara, Chia Lianwea, et al.
Leukemia & Lymphoma|September 20, 2019
Mechanisms of intrinsic and acquired resistance to venetoclax in B-cell lymphoproliferative diseasePiers Blombery
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Pageof 1,001